Volume 19 Issue 9
Sep.  2021
Turn off MathJax
Article Contents
LIU Jiao, FANG Ru-meng, WANG Tao, LI Zhi-jun. Analysis of clinical features and prognosis of antineutrophil cytoplasmic antibody with infection[J]. Chinese Journal of General Practice, 2021, 19(9): 1480-1483. doi: 10.16766/j.cnki.issn.1674-4152.002091
Citation: LIU Jiao, FANG Ru-meng, WANG Tao, LI Zhi-jun. Analysis of clinical features and prognosis of antineutrophil cytoplasmic antibody with infection[J]. Chinese Journal of General Practice, 2021, 19(9): 1480-1483. doi: 10.16766/j.cnki.issn.1674-4152.002091

Analysis of clinical features and prognosis of antineutrophil cytoplasmic antibody with infection

doi: 10.16766/j.cnki.issn.1674-4152.002091
Funds:

 2018jyxm0832

  • Received Date: 2021-02-17
    Available Online: 2022-02-15
  •   Objective  To analyse the clinical characteristics of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) co-infection and to explore the main risk factors that affect the occurrence of infection and the impact of infection on the prognosis of patients.   Methods  A retrospective analysis was conducted on 118 AAV patients admitted to our hospital in the past 6 years. The patients were divided into the infected group (72 cases) and non-infected group (46 cases). The clinical data of the two groups were compared, and the clinical characteristics of co-infection were analysed. Single factor analysis was used to analyze the risk factors of infection. Then, logistic regression analysis was used to explore the independent risk factors that affect the occurrence of infection. The patient's survival curve was drawn, and the impact of infection on patient's prognosis was explored.   Results  About 61.02% AAV patients had co-infection, fever, cough and sputum, malaise, muscle aches and severely increased ESR and CRP. significant increase in the infected group. Univariate analysis showed that there was significant difference between the two groups in advanced age, increased white blood cell count, decreased lymphocyte count, reduced haemoglobin, reduced albumin, increased C-reactive protein, increased erythrocyte sedimentation rate, electrolyte disturbances (decreased serum sodium ion concentration, serum chloride ion concentration, serum potassium ion concentration), higher BVAS score, use of cyclophosphamide. Multivariate analysis showed that decreased lymphocyte count and decreased serum potassium ion concentration were independent risk factors affecting infection in AAV patients; co-infection could significantly shorten the survival period of patients.   Conclusion  AAV is prone to co-infection, with respiratory infections being the most common. Multiple risk factors often lead to infection in AAV patients, amongst which decreased lymphocyte count and serum potassium ion concentration are independent risk factors for co-infection. Infection can accelerate the death of patients. Active prevention and treatment of infection can improve the prognosis of AAV patients.

     

  • loading
  • [1]
    PAGNOUX C. Updates in ANCA-associated vasculitis[J]. Eur J Rheumatol, 2016, 3(3): 122-133. doi: 10.5152/eurjrheum.2015.0043
    [2]
    SCOTT J, HARTNETT J, MOCKLER D, et al. Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review[J]. Autoimmun Rev, 2020, 19(11): 102660. doi: 10.1016/j.autrev.2020.102660
    [3]
    ADDY C, DORAN G, JONES A L, et al. Microscopic polyangiitis secondary to mycobacterium abscessus in a patient with bronchiectasis: A case report[J]. BMC Pulm Med, 2018, 18(1): 170. doi: 10.1186/s12890-018-0732-3
    [4]
    YANG L, XIE H L, LIU Z Z, et al. Risk factors for infectious complications of ANCA-associated vasculitis: A cohort study[J]. BMC Nephrol, 2018, 19(1): 138. doi: 10.1186/s12882-018-0933-2
    [5]
    MCGREGOR J G, NEGRETE-LOPEZ R, POULTON C J, et al. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function[J]. Nephrol Dial Transpl, 2015, 30(1): i171-i181. http://smartsearch.nstl.gov.cn/paper_detail.html?id=d46a0b285ac021c6a50021dc380a3e1b
    [6]
    HARISÁ H, POLNER K, ARÁNYI J, et al. Simple, Readily available clinical indices predict early and late mortality among patients with ANCA-associated vasculitis[J]. BMC Nephrol, 2017, 18(1): 76. doi: 10.1186/s12882-017-0491-z
    [7]
    THOMAS K, VASSILOPOULOS D. Infections and vasculitis[J]. Curr Opin Rheumatol, 2017, 29(1): 17-23. doi: 10.1097/BOR.0000000000000348
    [8]
    SCHIEFERMUELLER J, ALAOUR B, CALVER A, et al. Lesson of the month 1: Beware the atypical presentation: Eosinophilic granulomatosis with polyangiitis presenting as acute coronary syndrome[J]. Clin Med, 2017, 17(2): 180-182. doi: 10.7861/clinmedicine.17-2-180
    [9]
    ZHANG R, WANG S Y, ZHANG M, et al. Hyponatremia in patients with chronic kidney disease[J]. Hemodial Int, 2017, 21(1): 3-10. doi: 10.1111/hdi.12447
    [10]
    XU P C, TONG Z Y, CHEN T, et al. Hypoalbuminaemia in antineutrophil cytoplasmic antibody-associated vasculitis: Incidence and significance[J]. Clin Exp Rheumatol, 2018, 36(4): 603-611. http://www.ncbi.nlm.nih.gov/pubmed/29352844
    [11]
    袁瑞丽, 杨云娇, 李菁. 抗中性粒细胞胞浆抗体相关性血管炎感染患者淋巴细胞及CD4+ T细胞减少与死亡的相关性[J]. 中华临床免疫和变态反应杂志, 2020, 14(2): 49-54. https://www.cnki.com.cn/Article/CJFDTOTAL-OZHL202002007.htm
    [12]
    JENNETTE J C, NACHMAN P H. ANCA glomerulonephritis and vasculitis[J]. Clin J Am Soc Nephrol, 2017, 12(10): 1680-1691. doi: 10.2215/CJN.02500317
    [13]
    SHI L. Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes[J]. Rheumatol Int, 2013, 37(11): 1779-1788. http://www.onacademic.com/detail/journal_1000040080547210_7043.html
    [14]
    JONES R B, HIEMSTRA T F, BALLARIN J, et al. Mycophenolate mofetil versus cyclophosphamide for remission induction in anca-associated vasculitis: A randomised, non-inferiority trial[J]. Ann Rheum Dis, 2019, 78(3): 399-405. doi: 10.1136/annrheumdis-2018-214245
    [15]
    MARTÍNEZ-MARTÍNEZ M U, OOSTDAM H V, ABUD-MENDOZA C. Diffuse alveolar hemorrhage in autoimmune diseases[J]. Curr Rheumatol Rep, 2017, 19(5): 27. doi: 10.1007/s11926-017-0651-y
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Article Metrics

    Article views (263) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return